3.99
Precedente Chiudi:
$4.32
Aprire:
$4.32
Volume 24 ore:
44,195
Relative Volume:
0.37
Capitalizzazione di mercato:
$2.72M
Reddito:
-
Utile/perdita netta:
$-11.27M
Rapporto P/E:
-0.1863
EPS:
-21.4132
Flusso di cassa netto:
$-9.40M
1 W Prestazione:
-12.11%
1M Prestazione:
-32.43%
6M Prestazione:
-43.80%
1 anno Prestazione:
-70.00%
Dermata Therapeutics Inc Stock (DRMA) Company Profile
Nome
Dermata Therapeutics Inc
Settore
Industria
Telefono
(858)-223-0882
Indirizzo
3525 DEL MAR HEIGHTS RD., #322, SAN DIEGO
Confronta DRMA con altri titoli
Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
---|---|---|---|---|---|---|
![]()
DRMA
Dermata Therapeutics Inc
|
3.99 | 2.87M | 0 | -11.27M | -9.40M | -21.41 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
408.61 | 105.69B | 11.39B | 3.64B | 3.50B | 13.99 |
![]()
ALNY
Alnylam Pharmaceuticals Inc
|
481.07 | 61.52B | 2.46B | -319.09M | -52.09M | -2.4669 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
569.17 | 60.69B | 14.21B | 4.46B | 3.56B | 39.69 |
![]()
ARGX
Argen X Se Adr
|
837.28 | 50.05B | 3.06B | 1.28B | 447.35M | 19.67 |
![]()
ONC
Beone Medicines Ltd Adr
|
318.02 | 35.25B | 4.56B | -176.77M | 225.30M | -1.7177 |
Dermata Therapeutics Inc Borsa (DRMA) Ultime notizie
Chart overlay techniques for tracking Dermata Therapeutics Inc. Equity Warrant - newser.com
Applying Elliott Wave Theory to Dermata Therapeutics Inc.2025 Market Overview & Technical Confirmation Alerts - newser.com
What analysts say about Dermata Therapeutics Inc Equity Warrant stockLarge Cap Stability Picks & Receive Monthly Expert Trading Blueprints - earlytimes.in
Analyzing drawdowns of Dermata Therapeutics Inc. with statistical toolsEarnings Trend Report & Weekly Stock Breakout Alerts - newser.com
Is Dermata Therapeutics Inc. Equity Warrant stock poised for growthJuly 2025 Spike Watch & Low Risk High Win Rate Picks - newser.com
Risk vs reward if holding onto Dermata Therapeutics Inc. Equity WarrantBreakout Watch & Advanced Swing Trade Entry Plans - newser.com
Can Expleo Solutions Limited Survive Disruption in Its Core IndustryREITs Market Trends & Build Your Portfolio With Our Free Stock Scanner - earlytimes.in
How buybacks impact Dermata Therapeutics Inc. Equity Warrant stock valueJuly 2025 Technicals & Fast Exit and Entry Trade Guides - newser.com
What valuation multiples suggest for Dermata Therapeutics Inc. Equity Warrant stockMarket Activity Recap & Daily Volume Surge Signals - newser.com
Analyzing Dermata Therapeutics Inc. Equity Warrant with risk reward ratio chartsWeekly Profit Recap & Verified High Yield Trade Plans - newser.com
Why Dermata Therapeutics Inc. stock could outperform in 2025Weekly Investment Recap & Entry Point Confirmation Signals - newser.com
Advanced analytics toolkit walkthrough for Dermata Therapeutics Inc. Equity Warrant2025 Geopolitical Influence & Intraday High Probability Alerts - newser.com
Momentum divergence signals in Dermata Therapeutics Inc. Equity Warrant chartEarnings Recap Report & Fast Moving Stock Watchlists - newser.com
How to monitor Dermata Therapeutics Inc. Equity Warrant with trend dashboardsJuly 2025 PostEarnings & Free Weekly Chart Analysis and Trade Guides - newser.com
Developing predictive dashboards with Dermata Therapeutics Inc. dataJuly 2025 Earnings & Fast Moving Stock Watchlists - newser.com
Pattern recognition hints at Dermata Therapeutics Inc. upsideWeekly Trade Analysis & Accurate Buy Signal Alerts - newser.com
Historical volatility pattern of Dermata Therapeutics Inc. visualizedPortfolio Update Report & Weekly High Conviction Trade Ideas - newser.com
Dermata Therapeutics announces $2.55M private offering - MSN
Short interest data insights for Dermata Therapeutics Inc. Equity WarrantJuly 2025 PostEarnings & Technical Confirmation Alerts - newser.com
Using R and stats models for Dermata Therapeutics Inc. forecastingJuly 2025 Outlook & Short-Term High Return Ideas - newser.com
Analyzing drawdowns of Dermata Therapeutics Inc. Equity Warrant with statistical tools2025 Risk Factors & Reliable Breakout Forecasts - newser.com
Technical analysis overview for Dermata Therapeutics Inc. Equity Warrant stock2025 Support & Resistance & Long-Term Safe Return Strategies - newser.com
Does Dermata Therapeutics Inc. qualify in momentum factor screeningMarket Risk Analysis & Weekly High Potential Alerts - newser.com
Why Dermata Therapeutics Inc. stock remains a top recommendationJuly 2025 Outlook & AI Powered Trade Plan Recommendations - newser.com
Will Dermata Therapeutics Inc. Equity Warrant price bounce be sustainableEarnings Growth Summary & Real-Time Chart Breakout Alerts - newser.com
What drives Dermata Therapeutics Inc stock priceMarket Correction Analysis & Low Risk Investment Tips - earlytimes.in
Why Telomir Pharmaceuticals Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket - Benzinga
News impact scoring models applied to Dermata Therapeutics Inc. Equity Warrant2025 Price Momentum & Smart Money Movement Tracker - newser.com
What the charts say about Dermata Therapeutics Inc. Equity Warrant today2025 Fundamental Recap & Smart Allocation Stock Tips - newser.com
Is Dermata Therapeutics Inc. Equity Warrant stock a top pick in earnings seasonMarket Sentiment Report & Community Verified Trade Alerts - newser.com
Why Dermata Therapeutics Inc. Equity Warrant stock is a must watch in 2025Market Growth Summary & Real-Time Chart Breakout Alerts - newser.com
Measuring Dermata Therapeutics Inc. Equity Warrant’s beta against major indicesJuly 2025 Outlook & Weekly High Return Stock Opportunities - newser.com
What momentum shifts mean for Dermata Therapeutics Inc. Equity WarrantWeekly Trade Analysis & Consistent Profit Trade Alerts - newser.com
Psyence Biomedical Stock Price, Quotes and Forecasts | NASDAQ:PBM - Benzinga
Advanced analytics toolkit walkthrough for Dermata Therapeutics Inc.Long Setup & Weekly Setup with ROI Potential - newser.com
Dermata Therapeutics Inc Azioni (DRMA) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):